Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-04-21 00:00:00 ET · period of report 2022-04-19 · accession 0001209191-22-025159 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-21 | 2022-04-19 | FATE | Chu Yu-Waye | Chief Medical Off | S - Sale | $35.37 | -4,062 | 151.0K | -3% | -$143.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-19 | S | D | 4,062 | $35.37 | 151,033 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $35.10 to $35.50 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. |